Selank
10 mg98.5% purityLot #SELANK-2026-001
SKU of selected dimension: PEP-SELANK-10MG
Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.
€67.10incl. VAT
✅ In Stock (40)
Volume pricing
| Quantity | Unit price | Savings |
|---|---|---|
| 1 vial | 67.10 € | — |
| 3 vials (−7%) | 62.22 € | −7% |
| 5 vials (−12%) | 58.56 € | −13% |
Ratings & reviews
Log in to rate this product after your order arrives. login
Certificate of Analysis
Lab Verified✓View certificate before purchase — transparency guaranteed
Research Profile
Selank — scientific profile
Content is for educational and research purposes. Research Use Only.
- Selank is a laboratory-developed heptapeptide with anxiolytic properties, originally created at the Institute of Molecular Genetics of the Russian Academy of Sciences. Its structure is derived from tuftsin, a naturally occurring immunomodulatory peptide (threonyl-lysyl-prolyl-arginine), which was modified by adding a Gly-Pro fragment to improve stability and biological activity. Through its influence on both GABAergic and serotonergic signaling pathways, Selank produces pronounced anti-anxiety effects that have been shown to be comparable to benzodiazepines, yet without causing sedation, cognitive dulling, or dependency. In Russia, Selank has been approved as a prescription treatment for generalized anxiety disorder. Studies further indicate that it promotes BDNF (Brain-Derived Neurotrophic Factor) production, supports memory formation, and regulates IL-6 cytokine activity, contributing to both neurological and immune benefits.
